Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
It's never too early to think about retirement. Learn when to start planning for your retirement and ensure financial stability.
26,408 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A dramatic daily swing has SpaceX briefly tumbling below Amazon in market cap. Here's how to judge which growth stock...
Can a struggling retailer reinvent itself into a Berkshire Hathaway-style holding company? This article weighs the bl...
As JJSF prepares for its 2026 earnings call, investors will scrutinize margins, pricing power, and capital allocation...
If SpaceX eyes an IPO, the idea of a space-faring civilization could reshape how investors evaluate growth and risk. ...
Apple just pulled back after a strong run, leaving investors wondering if now is the time to buy. This article uses h...
AI is nearing a dramatic turning point. Wedbush predicts a 2026 inflection, and this article explains what that means...
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Climate risk scores are moving from a niche risk tool to a gatekeeper in many loan deals. This article breaks down wh...
A five-year plumbing dispute in a premium Manhattan co-op escalates into questions about the building’s finances. Thi...
A quarterly filing reveals Adams Wealth Management reduced its holdings in the iShares AAA CLO Active ETF (CLOA). The...
In 2026, investors face a choice between a global industrial leader and a defense-focused specialist. This guide brea...